The California Institute for Regenerative Medicine (CIRM) is a major funding agency for stem cell research in the Golden State. Since voters approved the establishment of the agency in 2004, the CIRM has spent billions on research and facilities with the aim of making California the stem cell capital of the US. Now, in a move to advance that research mission even further, the agency has announced awards of $32M to investigators and stem cell companies to create a biobank of diseased cell lines for the use of researchers around the world. Called the Human Induced Pluripotent Stem Cell (hiPSC) Initiative Awards, the project will generate and ensure the availability of high quality disease-specific hiPSC resources for disease modeling, target discovery and drug discovery and development for prevalent, genetically complex diseases.
Tags: 2014, CA, 2013, Stem cell research, Southwest, California, Los Angeles, Biobank, biobanking, LAVS, San Diego, SDVS, San Francisco, SFVS, UC San Diego, Biotechnology Vendor Showcase, UC San Francisco, CIRM, Parnassus Campus, tradeshow, Mission Bay Campus, Parnassus, Mission Bay, BVS, UC Los Angeles
UCSF, Mission Bay biomedical research programs are developing and expanding at a rapid rate. Currently, the university has more ongoing biomedical construction projects than anywhere else in the world. Many new research centers and institutes are appearing in spaces that also contain areas for clinical trials and patient care.
Tags: CA, Southwest, 2012, San Francisco, SFVS, Biotechnology Vendor Showcase, new facilities, UC San Francisco, new Building, bio medical research